The classification of amyloid deposits in clinicopathological practice

Histopathology

Volumn 29, Issue 4, 1996, Pages 325-335

  Rocken C ^a,c   Schwotzer, E B ^a   Linke, R P ^b   Saeger, W ^a  

^a Marienkrankenhaus ^*  (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c WARRINGTON AND HALTON HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Amyloid; Biopsy; Immunohistochemistry

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; AMYLOID B PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029816662     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1996.tb01416.x     Document Type: Article

References (62)

1. Glenner GG. Amyloid deposits and amyloidosis. The 3-fibrilloses. New. Engl. J. Med. 1980; 302; 1283-1292.
2. Glenner GG. Amyloid deposits and amyloidosis. The 3-fibrilloses. New. Engl. J. Med. 1980; 302; 1333-1343.
3. Lansbury, PT Jr. In pursuit of the molecular structure of amyloid plaque: New technology provides unexpected and critical information. Biochemistry 1992; 31; 6865-6870.
4. Kazatchkine MD, Husby G, Araki S, et al. Nomenclature of amyloid and amyloidosis-WHO-IUIS nomenclature subcommittee. Bull. Who 1993; 71; 105-108.
5. Störkel S, Stürer A. Kombinierte Amyloidose vom Typ AA und AB nach chronischer Hämodialysc. Pathologe 1989; 10; 107-113.
6. Fernandez-Alonso J, Rios-Camacho C, Valenzuela-Castano A, Hernanz-Mediano W. Mixed systemic amyloidosis in a patient receiving long term haemodialysis. J. Clin. Pathol. 1994; 47; 560-561.
7. Röcken C, Saeger W, Linke RP. Mehrere unterschiedliche Amyloidtypen bei einer 93-jährigen Patientin: Kasuistik eines Sektionsfalles. Pathologe 1993; 14; 42-46.
8. Missmahl HP. Die Beeinflussung des polarisierten Lichtes durch die Amyloidsubstanz. Ann. Histochim. Suppl. 1962; 2; 225-234.
9. Baretton G, Linke RP, Löhrs U. Systemische Amyloidosen. Immunhistochemische Typisierung an Autopsien mit Hilfe zahlreicher spezifischer Antikörper. Pathologe 1990; 11; 71-79.
10. Bohle A, Wehrmann M, Eissele R et al. The long-term prognosis of AA and AL renal amlyoidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Path. Res. Pract. 1993; 189; 316-331.
11. Fujihara S. Differentiation of amyloid fibril proteins in tissue sections. Two simple and reliable histological methods applied to fifty-one cases of systemic amyloidosis. Acta Pathol. Jap. 1982; 32; 771-782.
12. Linke RP, Nathrath WBJ, Eulitz M. Classification of amyloid syndromes from tissue sections using antibodies against various amyloid fibril proteins: report of 142 cases. In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, Nucker-Franklin D eds. Amyloidosis. New York. London: Plenum Publishing Corporation, 1986; 599-605.
13. Röcken C, Saeger W, Linke RP. Gastrointestinal amyloid deposits in old age. Report on 110 consecutive autopsical patients and 98 retrospective bioptic specimens. Path. Res. Pract. 1994; 190; 641-649.
14. Linke RP, Gärtner HV, Michels H. High-sensitivity diagnosis of AA amyloidosis using Congo Red and immunohistochemistry detects missed amyloid deposits. J. Histochem. Cytochem. 1995; 43; 863-869.
15. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine 1975; 54; 271-299.
16. Puchtler H, Waldrop FS, Meloan SN. A review of light, polarization and fluorescence microscopic methods for amyloid. Appl. Pathol. 1985; 3; 5-17.
17. van de Kaa CA, Hol PR, Hubor J, Linke RP, Kooiker CJ, Gruys E. Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins, Virchows Archiv [A] 1986; 408; 649-664.
18. Puchtler H, Sweat F, Levine M. On the binding of Congo Red by amyloid. J. Histochem. Cytochem. 1962; 10; 355-364.
19. Linke RP. Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis. J. Histochem. Cytochem. 1984; 32; 322-328.
20. Linke RP. Immunochemical typing of amyloid deposits after microextraction from biopsies. Appl. Pathol 1985; 3; 18-28.
21. Linke RP. Immunohistocheinical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropalhy. Lack of reactivity with cerebral amyloid in Alzheimer's disease. Clin. Neuropathol. 1982; 1: 172-182.
22. Linke RP, Kerling A, Rail A. Hemodialysis: demonstration of truncated β2-microglohnlin in AB-amyloid in situ. Kidney Int. 1993; 43; S-100-S-105.
23. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B. Potential role of apolipoprotein-E in fibrillogenesis. Am. J. Pathol. 1994; 145; 526-530.
24. Prelli F, Pras M. Shtrasburg S, Frangione B. Characterization of high molecular weight amyloid A proteins. Scand. J. Immunol. 1991; 33, 783-786.
25. Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B. Is Alzheimer's disease an apolipoprotein F amyloidosis? Lancet 1995; 345: 956-958.
26. Kisilevsky R. Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition. J. Int. Med. 1992; 232; 515-516.
27. Schultz RT. Role of altered vascular permeability in amyloid formation. Am. J. Pathol. 1977; 86; 321-334.
28. Fujihara S, Balow JE, Costa JC, Glenner GG. Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabeled immunoperoxidase method. Lab. Invest. 1980; 43; 358-365.
29. Glenner GG, Linke RP, Pollock PS. Systemic amyloidosis and immunoglobulins. In: Wegelius O, Pasternack A, eds. Amyloidosis. London, New York: Academic Press, 1976; 233-246.
30. Lyon AW, Narindrasorasak S, Young ID et al. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Lab. Invest. 1991; 64: 785-790.
31. Westermark GT, Norling B, Westermark P. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis. Clin. Exp. Immunol. 1991; 86; 150-156.
32. Ishii T, Haga S, Yagishita S, Tateishi J. The presence of complements in amyloid plaques of Creutzfeldt-Jacob disease and Gerstmann-Straussler-Scheinker disease. Appl. Pathol. 1984; 2; 370-379.
33. Wisniewski T, Golabek AA, Kida E, Wisniewski KE, Frangione B. Conformational mimicry in Alzheimer's disease: role of apolipoproteins in amyloidogenesis. Am. J. Pathol. 1995; 147; 238-244.
34. Rebeck GW, Harr SD, Strickland DK, Hyman BT. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α(2)-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Am. Neurol. 1995; 37; 211-217.
35. Kaplan B, German G, Pras M. Isolation and characterization of amyloid proteins using milligram amounts of amyloid-containing tissue. J. Liq. Chromatogr. 1993; 16; 2249-2268.
36. Westermark P, Benson L, Olofsson BO. Fine needle aspiration biopsy of abdominal subcutaneous fat tissue for the diagnosis and typing of amyloidosis. In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, Zucker-Franklin D, eds. Amyloidosis. New York, London: Plenum Publishimg Corporation, 1986; 613-615.
37. Yakar S, Kaplan B, German G et al. Quantification of tissue amyloid content in AA amyloidosis by inhibition ELISA. Amyloid 1995; 2; 167-172.
38. Strege R, Saeger W, Röcken C, Missmahl HP, Linke RP. Systemic amyloidoses in autopsies: immunohistochemical classification and correlation to basic disease. Path. Res. Pract. 1995; 191; 207.
39. Gafni J, Sohar E. Rectal biopsy for the diagnosis of amyloidosis. Amer. J. Med. Sci. 1960; 240; 102/332-106/336.
40. Kyle RA, Spencer RJ, Dahlin DC. Value of rectal biopsy in the diagnosis of primary systemic amyloidosis. Amer. J. Med. Sci. 1966; 251; 35/501-40/506.
41. Missmahl HP. Rektumbiopsie zum Nachweis der Amyloidose. Dtsch. Med Wochenschr. 1963; 88; 1783-1785.
42. Ortila C, Giraud P, Modesto A, Suc JM. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum. Pathol. 1986; 17; 366-369.
43. Ii K, Kyle RA, Dyck PJ. Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy. Am. J. Pathol. 1992; 141: 217-226.
44. Frenzel H, Schwartzkopff B, Kuhn H et al. Cardiac amyloid deposits in ondomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochomical studies. Am. J. Clin. Pathol. 1986; 85; 674-680.
45. Olson LJ, Gertz MA, Edwards WD et al. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemislry. New. Engl. J. Med. 1987; 317: 738-742.
46. Silvestri F, Tanganelli P, Salvi A et al. Cardiac amyloidosis: five cases diagnosed by endomyocardial biopsy. Appl. Pathol. 1985; 3; 69-77.
47. Jansen S, Elema JD, Rijswijk, MH, van Limburg PC, Meijer S, Mandema E. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method In differentiating AA from AL amyloidosis. Appl. Pathol. 1985; 3; 29-58.
48. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 1995; 38; 242-247.
49. Löfberg H, Thysell H, Westman K et al. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type. Acta Pathol Microbial. Immunol Scand. A. 1987; 95; 357-363.
50. Solomon A, Weiss DT. AL Amyloidosis. In Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and Amyloidosis 1993. New York. London: Parthenon Publishing, 1994; 200-205.
51. Shirahama TS. Cohen AS. Intralysosomal formation of amyloid fibrils. Am. J. Pathol. 1975; 81; 101-116.
52. Blum A, Sohar E. The diagnosis of amyloidosis. Ancillary procedures. Lancet 1962; 7; 721-723.
53. Yamada M, Hatakeyamu S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum. Pathol. 1985; 16; 1206-1211.
54. Chastonay P, Hurlimann J. Characterization of different amyloids with immunological techniques. Path. Res. Prant. 1986; 181; 657-663.
55. Klemi PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand. J. Rheumatol. 1987; 16; 429-431.
56. Stein K, Störkel S, Linke RP, Goebel HH. Chemical heterogeneity of amyloid in the carpal tunnel syndrome. Virchows Archiv. [A] 1987; 412; 37-45.
57. Iwata T, Yokota T, Ishihara T et al. Histologic characterization of amyloidosis based on amyloid proteins. In: Isobe T, Araki S, Uchino F, Kito S, Tsubura E, eds. Amyloid and Amyloidasis. New York. London: Plenum Publishing Corporation. 1988; 795-799.
58. Voigt C, Saeger W, Linke RP, Missmahl HP. Immunhistochemische Differenzierung von generalisierten Amyloidosen. Pathologe 1989; 10; 103-106.
59. Sungur C, Sungur A, Ruacan S et al. Diagnostic value of hone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever. Kidney Int. 1993; 44; 834-836.
60. Gallo G, Kaakour M, Kumar A, Chuba J, Waisman J. Immunohistologic classification of systemic amyloidosis by fat aspiration biopsy. Amyloid 1994; 1; 94-99.
61. Hoshii Y, Takahashi M, Ishihara T, Uchino F. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis. Pathol. Int. 1994; 44; 352-358.
62. Schmidt ML, Robinson KA, Lee, VMY, Trojanowski JQ. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and down's syndrome brains revealed by confocal microscopy. Am. J. Pathol. 1995; 147; 503-515.